comparemela.com

Latest Breaking News On - நிர்வகித்தல் அறிவுசார் ப்ராபர்டீ - Page 1 : comparemela.com

Anna Naydonov Intellectual property Litigation Lawyer Finnegan Law Firm

Legal Disclaimer You are responsible for reading, understanding and agreeing to the National Law Review s (NLR’s) and the National Law Forum LLC s  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

People & Practices: May 10, 2021

Fish & Richardson announced  Betsy Flanagan has been named the managing principal of the Twin Cities office. She succeeds J. Patrick Finn III, Ph.D., who served in the role since 2015. The Twin Cities office houses over 30 IP attorneys and technology specialists, as well as the firm’s administrative hub for support staff. Flanagan’s practice focuses on complex patent litigation, with an emphasis on life sciences, biotechnology and pharmaceutical litigation, including Hatch-Waxman litigation. She has worked on a variety of technologies, including pharmaceutical formulations, glaucoma drugs, hair growth agents, dermal fillers, nucleosides, antibodies, biologics, and sleep apnea devices. Flanagan has been widely recognized in Minnesota and nationally for her patent litigation work. Most recently, she was named the Litigation Practitioner of the Year for Minnesota by 

Element Biosciences Appoints Chief Commercial Officer, General Counsel, and VP of Operations

Element Biosciences Appoints Chief Commercial Officer, General Counsel, and VP of Operations By Staff 2 seconds ago Former Thermo Fisher Scientific, Apple, and Becton Dickinson executives bring commercial, legal, and operational expertise to Element’s leadership team SAN DIEGO, Calif.–(BUSINESS WIRE)–Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointments of Jeff Journey as Chief Commercial Officer, David Melaugh as General Counsel, and Jeff Labbadia as VP of Operations. “We are thrilled to welcome Jeff, David, and Jeff to the Element team,” said Molly He, Ph.D., CEO and co-founder of Element. “They are strategic leaders in the technology and life science industry, each with an impressive track record in building and scaling best-in-class commercial, legal, and operations teams, respectively. As we gear up for production and commercialization of our first product, the depth and breadth of their experience wi

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.